Shasun Pharmaceuticals Ltd.[Merged] - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Sep ' 15	Sep ' 14	Sep ' 13	Mar ' 13	Sep ' 12

Sales

526.01

529.99

399.19

406.08

376.68

Operating profit

58.72

47.06

34.04

28.91

39.22

Interest

20.44

20.70

16.55

14.92

11.57

Gross profit

43.51

32.77

22.01

24.27

31.03

EPS (Rs)

2.78

2.55

2.48

2.32

2.38

Other income

5.23

6.41

4.52

10.28

3.38

Stock adjustment

-11.05

21.37

-26.52

-5.90

-11.88

Raw material

304.57

294.10

248.75

261.15

239.82

Power and fuel

-

-

-

-

-

Employee expenses

59.09

55.65

45.74

39.41

37.33

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

114.68

111.81

97.18

82.51

72.19

Provisions made

-

-

-

-

-

Depreciation

22.68

17.43

18.19

17.30

14.36

Taxation

2.11

-

-10.23

-6.20

3.56

Net profit / loss

18.72

15.34

14.05

13.17

13.11

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

13.45

12.03

11.33

11.33

11.03

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

434.81

363.81

328.61

325.61

325.52

Agg.of non promotoholding (%)

64.68

60.51

58.03

57.50

59.05

OPM (%)

11.16

8.88

8.53

7.12

10.41

GPM (%)

8.19

6.11

5.45

5.83

8.16

NPM (%)

3.52

2.86

3.48

3.16

3.45